Medication info
Furotan Tablet (Losartan Potassium)

Furotan Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
KS Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202003304 · Approved 2020.05.07 · Insurance code 059000830

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
Who takes it
Adults · Children
Adult dose
This medication may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once a day. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or the dose may be increased to 100 mg once a day if needed. 3) If blood pressure is not controlled with this medication alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medication once a day. Depending on blood pressure, the dose may be increased to 100 mg once a day. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medication may be administered in combination with insulin or commonly used antidiabetic drugs (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary for older adults up to 75 years of age. For older adults over 75 years of age, an initial dose of 25 mg of this medication once a day is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medication once a day is recommended. 3) Patients with reduced intravascular volume For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medication once a day is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medication once a day, which may be increased to a maximum of 50mg once a day depending on the patient's blood pressure response. Children and adolescents 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medication once a day, which may be increased to a maximum of 100 mg once a day depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
KS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension

  • Hypertension
  • type 2 diabetes
  • kidney disease
View approved original text

This medication is used in the treatment of hypertension, particularly in preventing or slowing the progression of kidney disease in patients with type 2 diabetes and hypertension. Thus, it is useful in maintaining cardiovascular health and protecting kidney function.

How to take

Adult dose

This medication may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once a day. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or the dose may be increased to 100 mg once a day if needed. 3) If blood pressure is not controlled with this medication alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medication once a day. Depending on blood pressure, the dose may be increased to 100 mg once a day. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medication may be administered in combination with insulin or commonly used antidiabetic drugs (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No adjustment of the initial dose is necessary for older adults up to 75 years of age. For older adults over 75 years of age, an initial dose of 25 mg of this medication once a day is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medication once a day is recommended. 3) Patients with reduced intravascular volume For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medication once a day is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medication once a day, which may be increased to a maximum of 50mg once a day depending on the patient's blood pressure response. Children and adolescents 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medication once a day, which may be increased to a maximum of 100 mg once a day depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This drug may cause serious damage to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be immediately discontinued upon confirmation of pregnancy. Taking this drug during pregnancy can inhibit the development of the fetus's lungs and increase the risk of problems such as skeletal deformities or kidney dysfunction. This drug should not be administered to pregnant women or women of childbearing potential. Patients with severely impaired liver function, certain hereditary diseases, or allergies to this medication or its components should not take it. Caution should be exercised in elderly patients, patients with compromised kidney function, and patients at risk for sudden drops in blood pressure when using this medication. Side effects can include dizziness, muscle cramps, back pain, cough, headaches, dyspepsia, among others, and rarely, serious reactions such as angioedema or liver function abnormalities may occur. Since this drug lowers blood pressure, it should be discontinued immediately and medical attention sought if symptoms of hypotension or loss of consciousness occur. There is a risk of elevated potassium levels, so care must be taken not to take potassium supplements or potassium-containing medications concurrently. Patients taking this medication should have their blood pressure, kidney function, and blood potassium levels monitored regularly, and any abnormal signs should be reported to their healthcare provider. Breastfeeding women are advised not to take this medication, and if necessary, should discontinue breastfeeding. This medication will not be administered to children, especially those under 6 years of age or those with significantly compromised kidney function. This drug may interact with other blood pressure medications or specific medications, so be sure to inform your doctor or pharmacist of any current medications being taken. When storing the medication, keep it out of reach of children and do not transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lumbago
  • leg pain
  • dizziness
  • congestion
Show 137 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • sensory disturbances
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • phototoxic reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning sensation
  • pain
  • conjunctivitis
  • taste disturbances
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • pollakiuria
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic-like reaction syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • creatine kinase elevation
  • rhabdomyolysis
  • acute renal failure
  • dry cough
  • erythema multiforme
  • hyponatremia
  • ALT elevation
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • transient shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic contractions
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • impaired consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. A storage temperature of between 1 and 30 degrees Celsius is recommended. Proper storage will maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.